Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2024
2021
2013
Europe
Clear all
Type of publications
NITAG documentation
(76)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Europe
(81)
Africa
(20)
Americas
(72)
South-East Asia
(4)
Western Pacific
(17)
Countries
Belgium
(15)
Denmark
(1)
France
(18)
Germany
(8)
Ireland
(7)
Netherlands
(6)
Spain
(3)
Sweden
(2)
United Kingdom
(20)
Diseases
COVID-19
(77)
Human papillomavirus (HPV)
(4)
Diphtheria
(1)
Hepatitis A
(2)
Hepatitis B
(3)
Herpes zoster
(1)
Influenza
(8)
Measles
(2)
Meningococcal disease
(2)
Pertussis
(1)
Pneumococcal disease
(3)
Rotavirus
(3)
Streptococcus group B
(1)
Tetanus
(1)
Varicella
(2)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Economic aspects
(1)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(3)
Healthcare workers
(1)
Older adults
(1)
Pregnant women
(1)
Risk group
(2)
Publication date
2024
(1)
2021
(77)
2013
(3)
2023
(14)
2022
(38)
2020
(21)
2019
(6)
2018
(7)
2017
(9)
2016
(3)
2015
(4)
2014
(7)
2012
(1)
2011
(2)
2010
(1)
2009
(2)
2008
(2)
2007
(3)
81 results found
2024
∙
JCVI
JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination
2021
∙
Kamal, A. Hodson, A. Pearce, J. M.
A rapid systematic review of factors influencing covid‐19 vaccination uptake in minority ethnic groups in the uk
2021
∙
Escriva-Boulley, G. Mandrik, O. Preau, M. Herrero, R. Villain, P.
Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review
2021
∙
Kuznetsova, L. Cortassa, G. Trilla, A.
Effectiveness of mandatory and incentive-based routine childhood immunization programs in europe: A systematic review of the literature
2021
∙
STIKO
1st STIKO update on the COVID-19- Vaccination recommendation and the associated scientific Reason
2021
∙
STIKO
2nd STIKO update of the COVID-19 Vaccination recommendation and the associated scientific Reason
2021
∙
Conseil Supérieur de la Santé (CSS)
Belgian recommendation of an additional dose of COVID-19 mRNA vaccine (Part one)
2021
Booster dose after Janssen vaccine
2021
Booster dose for healthcare workers
2021
Booster vaccination against COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register